Annu Rev Physiol (2017) 79:31334
Metformin, a biguanide antihyperglycemic agent widely used for type 2 diabetes, has attracted interest due to its insulin-sensitizing properties, but its role in treating fatty liver remains investigational and controversial
This moment is a testnot just of these medications, but of whether our industry can rise to meet the challenge of long-term, whole-person health
Many patients and providers view these as long-term treatments rather than short-term interventions
Skin Cancer Education: A masterclass on the ABCDEs of melanoma and the critical importance of early detection and routine skin checks
Healthcare providers may consider: Bacterial culture if infection is suspected Temporary discontinuation of semaglutide to assess symptom resolution Referral to allergy/immunology for suspected hypersensitivity reactions For type 2 diabetes patients only, alternative GLP-1 receptor agonist formulations (such as oral semaglutide/Rybelsus) if injection site reactions are recurrent and problematic Patients with confirmed hypersensitivity to semaglutide should not continue the medication
